Nordson Medical and Fluid Solutions — Adjusted cost of sales decreased by 12.0% to -$108.17M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.7%, from -$101.36M to -$108.17M. This is a positive signal — lower values indicate better performance for this metric.
A lower ratio relative to sales indicates improved manufacturing efficiency or better pricing power, while an increase may signal rising input costs.
The direct costs associated with producing and delivering the goods sold by the Medical and Fluid Solutions segment, adj...
Standard segment-level cost metric; peers report this to demonstrate operational efficiency in manufacturing.
ndsn_segment_medical_and_fluid_solutions_adjusted_cost_of_sales| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$81.33M | -$81.33M | -$81.33M | -$81.33M | -$86.01M | -$86.01M | -$86.01M | -$86.01M | -$103.37M | -$101.36M | -$96.56M | -$108.17M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -5.7% | +0.0% | +0.0% | +0.0% | -20.2% | +1.9% | +4.7% | -12.0% |
| YoY Change | — | — | — | — | -5.7% | -5.7% | -5.7% | -5.7% | -20.2% | -17.8% | +6.6% | -6.7% |